NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $37,000 | +8.8% | 400 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $34,000 | +750.0% | 400 | +654.7% | 0.01% | +500.0% |
| Q1 2020 | $4,000 | -98.7% | 53 | -98.3% | 0.00% | -97.8% |
| Q4 2019 | $297,000 | +21.2% | 3,147 | +11.4% | 0.05% | +9.5% |
| Q3 2019 | $245,000 | -5.8% | 2,824 | -0.9% | 0.04% | -4.5% |
| Q2 2019 | $260,000 | -5.5% | 2,849 | -0.6% | 0.04% | -15.4% |
| Q1 2019 | $275,000 | -28.9% | 2,866 | -36.6% | 0.05% | -23.5% |
| Q4 2018 | $387,000 | -99.9% | 4,519 | +12.6% | 0.07% | +38.8% |
| Q3 2018 | $345,760,000 | +154257.1% | 4,013 | +34.9% | 0.05% | +40.0% |
| Q2 2018 | $224,000 | -6.7% | 2,974 | 0.0% | 0.04% | -14.6% |
| Q1 2018 | $240,000 | -13.0% | 2,974 | -9.7% | 0.04% | -14.6% |
| Q4 2017 | $276,000 | – | 3,295 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |